JPRN-C000000358未知2 期
A Phase II study of induction chemotherapy S-1 and CDDP in patients with FDG-PET positive N2 disease of non-small cell lung cancer. - Induction therapy for N2 positive NSCLC
试验速览
- 阶段
- 2 期
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. active interstitial pneumonia 2. active infectious disease 3. active other cancer 4. severe drug allergy 5. severe complications
研究者
相似试验
已完成
不适用
A Phase I study of induction chemotherapy with S-1 and Cisplatin plus intraperitoneal administration of Docetaxel for gastric cancer with peritoneal disseminatiogastric cancerJPRN-UMIN000002524Department of Surgery Graduate School of Medicine, Kyoto University15
进行中（未招募）
不适用
Phase I/II study on induction chemotherapy followed by chemoradiation with or without lapatinib, a dual EGFR/ErbB2 kinase inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinomaEUCTR2006-002667-33-BEEuropean Organisation for Research and Treatment of Cancer
已完成
2 期
The phase II study of induction chemotherapy with cetuximab/S-1/low dose cisplatin for oral squamous cell carcinoma patientsoral squamous cell carcinomaJPRN-UMIN000014632The workshop of chemotherapy for oral cancer55
招募中
不适用
A phase 2 study of induction chemotherapy followed by chemoradiotherapy for patients with borderline resectable pancreatic cancerPancreatic cancerJPRN-UMIN000034410Keio University School of Medicine40
进行中（未招募）
1 期
Phase I/II study of Induction Chemotherapy with weekly RAD001, Carboplatine and Paclitaxel in Unresectable or Inoperable Locally Advanced Head and NeckSquamous Cell Carcinoma (HNSCC) - CAPRAnresectable or Inoperable locally advanced head and neck squamous cellcarcinoma without any prior chemotherapy or radiotherapyMedDRA version: 9.1Level: PTClassification code 10041823Term: Squamous cell carcinomaEUCTR2008-005702-39-FRGERCOR50